HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dermatologist Survey Lacked Details, Choices To Support Neutrogena ‘#1 Recommended’ Claim

J&J Consumer's Arguments Rejected Again In Industry Self-Regulation Forum

Executive Summary

J&J failed to convince BBB National Program’s appeals panel a 2008 NAD decision supporting its “#1 dermatologist recommended” claim for Neutrogena should preclude another review. Panel says market has changed in 12 years since review of Unilever challenge and L’Oreal could make its own challenge.

You may also be interested in...



Once Was Enough For J&J In Supporting Neutrogena ‘#1 Recommended’ Advertising

J&J Consumer appeals National Advertising Division decision, arguing a “#1 claim” for its Neutrogena personal care line challenged by L’Oréal USA is materially similar to one that NAD attorneys found it supported more than a decade ago.

Neutrogena Is “#1 Dermatologist Recommended,” To Unilever’s Chagrin

Neutrogena is indeed the No. 1 brand recommended by dermatologists and may in most cases include the claim in its advertising for individual products, the National Advertising Division says July 30, siding against challenger Unilever

EU Sustainable Chemicals Program Could Impact 60% Of Fragrance Ingredients – Givaudan

Certain rose, jasmine, cedarwood, freesia, lavender, apple, orange and musk fragrance ingredients could be eliminated purely on the basis of hazard if EU sustainable chemical principles are implemented as discussed across sectors and regulatory programs, according to Givaudan’s Greg Adamson, senior VP, global regulatory affairs and product safety for fragrance and beauty.

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

RS151868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel